Abstract:BackgroundAutophagy is an important regulatory process to coordinate the homeostasis of intestinal epithelial cells under stress and mediate pathogen clearance. Fecal microbiota transplantation(FMT) is an important treatment for ulcerative colitis. In this study, we constructed autophagy activated/inhibited dextran sulfate sodium (DSS) induced colitis mice and observed whether FTM improve experimental colitis by regulating autophagy.MethodsThirty male BALB/c mice were randomly divided into five groups: healthy control group (Control), DSS induced colitis group (DSS), autophagy activated colitis group (DSS+RAPA), autophagy inhibited colitis group (DSS+CQ) and autophagy inhibited and FMT intervention group (DSS+CQ+FMT). 3% DSS drinking water was used to induce colitis, and the following interventions were given daily for seven days: Control group and DSS group were administered with PBS by gavage and intraperitoneal injection, DSS+RAPA group were administered with PBS by gavage and rapamycin (4mg/kg) by intraperitoneal injection, DSS+CQ group were administered with hydroxychloroquine (40mg/kg) by gavage and PBS by intraperitoneal injection, DSS+CQ+FMT group were administered with hydroxychloroquine (40mg/kg) and PBS by intraperitoneal injection, and eight hours later administered FMT from healthy mice (100µL/10g) by gavage. Disease activity index (DAI) were monitored daily. On the eighth day, colonic tissues were resected after the mice were euthanized. The colon length was recorded, and some tissues were collected for histopathologic evaluation, while some tissues for observing autophagy expression (P62, LC3B and TFEB) by PCRResultsDAI (P=0.0128), colon length (P=0.043), and colon histopathologic score (P=0.0392) of colitis mice were effectively improved by autophagy activation (rapamycin), while DAI (P=0.4178), colon length (P=0.0393) and colon histopathologic score (P=0.765) were worsened markedly by autophagy inhibition (hydroxychloroquine); After autophagy inhibition, the following indexes of colitis were still significantly improved by FMT: DAI (P=0.0205), colon length (P=0.0008) and colon histopathologic score (P=0.0015)(IDDF2021-ABS-0212 Figure 1A. Fecal microbiota transplantation ameliorated experimental colitis and up-regulated autophagy expression, IDDF2021-ABS-0212 Figure 1B. Fecal microbiota transplantation ameliorated experimental colitis and up-regulated autophagy expression, IDDF2021-ABS-0212 Figure 1C. Fecal microbiota transplantation ameliorated experimental colitis and up-regulated autophagy expression, IDDF2021-ABS-0212 Figure 1D. Fecal microbiota transplantation ameliorated experimental colitis and up-regulated autophagy expression), and the expression of the following autophagy genes were changed: P62 was significantly down-regulated (P=0.006), while LC3B and TFEB were significantly increased (P=0.0033; P=0.0039)(IDDF2021-ABS-0212 Figure 1E. Fecal microbiota transplantation ameliorated experimental colitis and up-regulated autophagy expression).ConclusionsAutophagy activation may be one of the mechanisms by which FMT improves DSS induced experimental colitis.

Fecal Microbiota Transplantation Repairs Intestinal Mucosal Barrier Injury in Mice with Ulcerative Colitis

Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice

Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation

Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis

Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum

Shifts and importance of viable bacteria in treatment of DSS-induced ulcerative colitis mice with FMT

Fecal Microbiota Transplantation Ameliorates Experimentally Induced Colitis in Mice by Upregulating AhR

Lower fecal microbiota transplantation ameliorates ulcerative colitis by eliminating oral-derived Fusobacterium nucleatum and virulence factor

Ulva lactuca polysaccharides combined with fecal microbiota transplantation ameliorated dextran sodium sulfate-induced colitis in C57BL/6J mice

Fecal Microbiota Transplantation from Sodium Alginate-Dosed and Normal Mice Mitigates Intestinal Barrier Injury and Gut Dysbiosis Induced by Antibiotics and Cyclophosphamide

Enterococcus faecium Alleviates Gut Barrier Injury in C57BL/6 Mice with Dextran Sulfate Sodium-Induced Ulcerative Colitis

Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation

The Evaluation of Fecal Microbiota Transplantation Vs Vancomycin in a Clostridioides Difficile Infection Model.

Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition

Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance

Protective Effects of Companilactobacillus crustorum MN047 against Dextran Sulfate Sodium-Induced Ulcerative Colitis: A Fecal Microbiota Transplantation Study

Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells

IDDF2021-ABS-0212 Fecal Microbiota Transplantation Ameliorates Experimental Colitis by Regulating Autophagy

Beneficial Effect of Faecal Microbiota Transplantation on Mild, Moderate and Severe Dextran Sodium Sulphate-Induced Ulcerative Colitis in a Pseudo Germ-Free Animal Model